NEW STUDY: Nearly 11% of women suffer ‘serious adverse events’ after taking abortion pill
Live Action News
Nancy Flanders
A new, first-of-its-kind study asserts that serious adverse events from mifepristone, the first drug in the abortion pill regimen, occur at a rate approximately 22 times higher than the rate reported on the Food and Drug Administration’s (FDA) label for the drug.
The study, “The Abortion Pill Harms Women,” published by the Ethics and Public Policy Center (EPPC), states that nearly 11% of women (10.93%) experience sepsis, infection, hemorrhaging, or other serious or life-threatening adverse events following a mifepristone abortion. This means one in ten women experience at least one serious complication from taking mifepristone within 45 days — 22 times higher than the “less than 0.5 percent” serious adverse events rate reported by the FDA on the mifepristone label, according to this study. The study authors state that serious adverse events in multiple categories were accounted for in the reported rate.